Adenocarcinoma Clinical Trials

207 clinical trials for Adenocarcinoma across international registries, including 25 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer — RECRUITING · PHASE2
• Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies — RECRUITING
• Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors — RECRUITING · PHASE1
• Use of Tracking Devices to Locate Abnormalities During Invasive Procedures — RECRUITING · NA
• DESTINY-PANTUMOUR04 — RECRUITING
• Evaluation of the Efficacy of Negative Pressure Wound Therapy on Perineal Healing Following Abdominoperineal Amputation — RECRUITING · NA
• Relacorilant With Nab-Paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma — RECRUITING · PHASE2
• Prospective Data Collection Initiative on Thoracic Malignancies — RECRUITING
• PARa-aOrtic LymphAdenectomy in Locally Advanced Cervical Cancer — RECRUITING · PHASE3
• Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab and Tislelizumab Combined Chemotherapy for the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma. — RECRUITING · PHASE3
• Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study — RECRUITING · NA
• Anatomical-Clinical Base of Adenocarcinoma Pancreatic — RECRUITING
• Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression. — RECRUITING · NA
• Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies — RECRUITING · PHASE1
• Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for Cancer — RECRUITING · NA
• Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma — RECRUITING · PHASE2
• PRIMER: Development of Daily Online Magnetic Resonance Imaging for Magnetic Resonance Image Guided Radiotherapy — RECRUITING
• SERum-bank for PANcreatic Cancer — RECRUITING
• Evaluation, in Humans, of the Correlation Between Hepatotoxicity, Neurotoxicity Induced by Oxaliplatin, and Blood Levels of HMGB1 — RECRUITING · NA
• Beyond TME Origins — RECRUITING · NA
• YOUNg Adults With Gastro-inteSTinal (GI) and nEuroendocrine canceRs. — RECRUITING
• A PHASE III MULTI-CENTER, OPEN-LABEL, SPONSOR-BLINDED, RANDOMIZED STUDY OF AZD0901 MONOTHERAPY COMPARED WITH INVESTIGATOR¿S CHOICE OF THERAPY IN SECOND- OR LATER-LINE ADULT PARTICIPANTS WITH ADVANCED/METASTATIC GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA EXPRESSING CLAUDIN18.2 — RECRUITING · PHASE3
• Radiotherapy + Chemoimmunotherapy Followed by Surgery in Patients With Limited Metastatic Gastric or GEJ Cancer — RECRUITING · PHASE2
• PHASE II TRIAL OF PERIOPERATIVE PD-L1 INHIBITION WITH AVELUMAB AND DOCETAXEL, CISPLATIN, AND 5-FLUOROURACIL FOR RESECTABLE LOCALLY ADVANCED ESOPHAGO-GASTRIC ADENOCARINOMA — RECRUITING · PHASE2
• "A PHASE III, RANDOMIZED, OPEN-LABEL CLINICAL TRIAL OF PEMBROLIZUMAB (MK-3475) VERUS PACLITAXEL IN SUBJECTS WITH ADVANCED GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA WHO PROGRESSED AFTER FIRST-LINE THERAPY WITH PLATINUM AND FLUOROPYRIMIDINE." — RECRUITING · PHASE3
• Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance — NOT_YET_RECRUITING · PHASE2
• Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer — TERMINATED · PHASE1
• Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells Delivered Intraperitoneally for the Management of Platinum Resistant Ovarian Cancer, Mesonephric-like Adenocarcinoma, and Pancreatic Cancer — SUSPENDED · PHASE1
• Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma — ACTIVE_NOT_RECRUITING · PHASE2
• A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1) — COMPLETED · PHASE2
• A Pilot Study to Assess Changes in Tumor Biology Following Second-line Treatment With Pembrolizumab Plus Lenvatinib in Patients With Advanced Pancreatic Ductal Adenocarcinoma — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• A MULTICENTER, FIRST-IN-HUMAN, DOSE ESCALATION AND OPTIMIZATION PHASE I/IIA STUDY TO INVESTIGATE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND EFFICACY OF THE NAPI2B ANTIBODY-DRUG CONJUGATE TUB-040 IN PATIENTS WITH PLATINUM-RESISTANT HIGH-GRADE OVARIAN CANCER (PROC) OR RELAPSED/REFRACTORY ADENOCARCINOMA NON-SMALL CELL LUNG CANCER (NSCLC) (NAPISTAR 1-01). — NOT_YET_RECRUITING · PHASE1
• Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer — COMPLETED · PHASE1
• Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD) — COMPLETED · PHASE2
• National Lung Matrix Trial: Multi-drug Phase II Trial in Non-Small Cell Lung Cancer — COMPLETED · PHASE2
• A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) — TERMINATED · PHASE3
• PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant Chemotherapy — COMPLETED · PHASE3
• Treatment of Multifocal Lung Adenocarcinoma — TERMINATED · NA
• Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc) — TERMINATED · PHASE2
• EchoTip AcuCore Post-Market Clinical Study — COMPLETED
• Preoperative Evaluation of Lymph Nodes of Cholangiocarcinoma — COMPLETED
• HER2-positive Locally Advanced/Metastatic Gastric and/or Gastroesophageal Junction (GEJ) Adenocarcinoma in Russia — COMPLETED
• Trial of Cabozantinib Plus Atezolizumab in Advanced and Progressive Neoplasms of the Endocrine System. The CABATEN Study — COMPLETED · PHASE2
• Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer — TERMINATED · PHASE2
• Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors — COMPLETED · PHASE1
• Study of High Dose Intravenous (IV) Ascorbic Acid in Measurable Solid Tumor Disease — WITHDRAWN · PHASE2
• A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer — COMPLETED · PHASE1
• A Study of Chemoradiation Associated with Nimotuzumab As the Treatment of Locally Advanced Esophageal Cancer — COMPLETED · PHASE2
• A Multicenter Clinical Trial of Sputum DNA Testing for Lung Cancer in China — COMPLETED

Refine this search